Myriad Genetics Inc (MYGN)

Cost of Revenue

$251.40M

TTM · Period ending: · USD

MYGN logo

MYGN Cost of Revenue

Latest reported$251.40M
MYGN TTM Cost of Revenue (-$1.80M → $251.40M)
High-resolution chart · PNG

MYGN cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Myriad Genetics Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
251,400,000
249,000,000
247,900,000
244,600,000
246,200,000
249,300,000
252,200,000
254,100,000
248,200,000
241,600,000
236,200,000
228,500,000
221,300,000
213,200,000
202,000,000
193,900,000
191,300,000
195,300,000
197,600,000
151,800,000
148,200,000
131,200,000
131,000,000
180,600,000
186,100,000
200,000,000
198,500,000
201,000,000
201,000,000
196,200,000
191,700,000
184,000,000
177,300,000
174,100,000
174,300,000
174,300,000
171,300,000
168,700,000
164,600,000
160,800,000
157,300,000
155,689,000
151,789,000
149,089,000
147,489,000
140,080,000
130,389,000
118,620,000
109,201,000
100,294,000
94,019,000
87,772,000
79,618,000
74,497,000
71,391,000
67,624,000
64,658,000
60,229,000
54,134,000
50,063,000
46,713,000
45,452,000
45,199,000
44,236,000
44,287,000
44,210,000
44,562,000
44,539,000
43,267,000
41,133,000
38,164,000
34,794,000
32,339,000
30,890,000
30,204,000
30,043,000
30,813,000
31,274,000
31,202,000
29,945,000
27,643,000
25,235,000
23,027,000
21,886,000
20,322,000
18,502,000
16,914,000
15,231,000
13,750,000
13,191,000
12,843,000
12,390,000
12,553,000
12,308,147
11,795,738
11,366,072
10,717,072
9,907,442
9,207,880
8,369,544
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.